Why L Brands Inc Stock Dropped 31% in 2016

Why L Brands Inc Stock Dropped 31% in 2016

What happened Shares of Victoria’s Secret parent L Brands, Inc. (NYSE:LB) weren’t looking so attractive last year, slipping 31% according to data from S&P Global Market Intelligence. Like many mass-market retailers, L Brands struggled as its quarterly sales results consistently missed the mark.  So what As the chart above shows, last year’s drop owes primarily to disappointing → Read More

Here's Everything You Need to Know About Microsoft Corporation's Latest AI Acquisition

Here's Everything You Need to Know About Microsoft Corporation's Latest AI Acquisition

Last week, Microsoft (NASDAQ:MSFT) made yet another leap forward in its already ambitious artificial intelligence (AI) plans when it scooped up AI start-up Maluuba.  The Montreal-based company is “one of the world’s most impressive deep learning research labs for natural language understanding”, according to Microsoft, and will help the tech giant pursue a monumental goal in → Read More

Why Ford Motor Company Is Revamping the Mustang for 2018

Why Ford Motor Company Is Revamping the Mustang for 2018

Ford Motor Company (NYSE:F) said on Tuesday that its iconic Mustang will receive a series of changes and upgrades for the 2018 model year. The Mustang was all new for the 2015 model year and isn’t exactly looking long in the tooth. But in keeping with the new business strategy that Ford announced last fall, the Mustang → Read More

Why Arista Networks, Progress Software, and Regions Financial Slumped Today

Why Arista Networks, Progress Software, and Regions Financial Slumped Today

The stock market lost ground on Tuesday, with the Dow Jones Industrials falling nearly 60 points and the S&P and Nasdaq posting similar declines. Investors are waiting anxiously to see whether anticipated new policies that President-elect Donald Trump has previously announced will actually become law in the near future, and others are nervous that potential → Read More

Is Donald Trump Celgene's Biggest Risk in 2017?

Is Donald Trump Celgene's Biggest Risk in 2017?

If biotech investors were hoping that the election of Donald Trump as the next president of the United States would mean an end to the risk of drug price controls, they might be mistaken. During a press conference last week, Trump called out drug companies for “getting away with murder” in terms of drug prices, → Read More

Apple Inc.'s “Super Cycle” Problem

Apple Inc.'s “Super Cycle” Problem

Later this year, Apple (NASDAQ:AAPL) is expected to launch new smartphones that will, per some analysts, catalyze a “super cycle” — essentially a significant acceleration in iPhone shipment growth because of a major fundamental change to the phones. The last such super cycle was the iPhone 6 cycle. Apple was late to bringing large-screen smartphones → Read More

Why Clayton Williams Energy, Forward Pharma, and Luxottica Jumped Today

Why Clayton Williams Energy, Forward Pharma, and Luxottica Jumped Today

Tuesday was a poor day for the stock market, as major market benchmarks were down between 0.3% and 0.6% on the day. Investors appear to view Friday’s inauguration of Donald Trump as president as a potential endpoint to the stock market rally of the past couple of months, and uncertainty about the priorities of the → Read More

Why Arista Networks, Inc. Stock Plunged Today

Why Arista Networks, Inc. Stock Plunged Today

What happened Shares of Arista Networks Inc. (NYSE:ANET) fell 12% on Tuesday on the heels of a negative court ruling in its ongoing patent infringement case with Cisco Systems (NASDAQ:CSCO). So what Late Friday, the U.S. Customs and Border Protection agency revoked its November ruling that redesigned products from Arista Networks don’t infringe a key patent → Read More

Can Amplify Snack Brands Keep Going After Last Week's 19% Pop?

Can Amplify Snack Brands Keep Going After Last Week's 19% Pop?

It’s not just kernels popping at Amplify Snack Brands (NYSE:BETR) these days. Shares of the company behind SkinnyPop popcorn, Oatmega grass-fed whey bars, and Paqui ground-corn tortilla chips moved 18.85% higher last week following a pair of encouraging analyst notes. Amplify Snack Brands stock was one of last week’s 10 biggest gainers on the New York Stock → Read More

MarketTamer is not an investment advisor and is not registered with the U.S. Securities and Exchange Commission or the Financial Industry Regulatory Authority. Further, owners, employees, agents or representatives of MarketTamer are not acting as investment advisors and might not be registered with the U.S. Securities and Exchange Commission or the Financial Industry Regulatory.


The sender of this email makes no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended in this email, and makes no representations or warranties concerning said company or entity’s compliance with applicable laws and regulations, including, but not limited to, regulations promulgated by the SEC or the CFTC. The sender of this email may receive a portion of the proceeds from the sale of any products or services offered by a company or entity mentioned or recommended in this email. The recipient of this email assumes responsibility for conducting its own due diligence on the aforementioned company or entity and assumes full responsibility, and releases the sender from liability, for any purchase or order made from any company or entity mentioned or recommended in this email.


The content on any of MarketTamer websites, products or communication is for educational purposes only. Nothing in its products, services, or communications shall be construed as a solicitation and/or recommendation to buy or sell a security. Trading stocks, options and other securities involves risk. The risk of loss in trading securities can be substantial. The risk involved with trading stocks, options and other securities is not suitable for all investors. Prior to buying or selling an option, an investor must evaluate his/her own personal financial situation and consider all relevant risk factors. See: Characteristics and Risks of Standardized Options. The www.MarketTamer.com educational training program and software services are provided to improve financial understanding.


The information presented in this site is not intended to be used as the sole basis of any investment decisions, nor should it be construed as advice designed to meet the investment needs of any particular investor. Nothing in our research constitutes legal, accounting or tax advice or individually tailored investment advice. Our research is prepared for general circulation and has been prepared without regard to the individual financial circumstances and objectives of persons who receive or obtain access to it. Our research is based on sources that we believe to be reliable. However, we do not make any representation or warranty, expressed or implied, as to the accuracy of our research, the completeness, or correctness or make any guarantee or other promise as to any results that may be obtained from using our research. To the maximum extent permitted by law, neither we, any of our affiliates, nor any other person, shall have any liability whatsoever to any person for any loss or expense, whether direct, indirect, consequential, incidental or otherwise, arising from or relating in any way to any use of or reliance on our research or the information contained therein. Some discussions contain forward looking statements which are based on current expectations and differences can be expected. All of our research, including the estimates, opinions and information contained therein, reflects our judgment as of the publication or other dissemination date of the research and is subject to change without notice. Further, we expressly disclaim any responsibility to update such research. Investing involves substantial risk. Past performance is not a guarantee of future results, and a loss of original capital may occur. No one receiving or accessing our research should make any investment decision without first consulting his or her own personal financial advisor and conducting his or her own research and due diligence, including carefully reviewing any applicable prospectuses, press releases, reports and other public filings of the issuer of any securities being considered. None of the information presented should be construed as an offer to sell or buy any particular security. As always, use your best judgment when investing.